Chemical Market Reporter - SULFASALAZINE.
October 4, 1999 -- SULFASALAZINE--MGI Pharma Inc. began co-promoting Azulfidine EN-tabs (sulfasalazine delayed release tablets, USP), Enteric-coated, in the US with...
Skin & Allergy News - Recalcitrant chronic urticaria may respond to sulfasalazine
July 1, 2006 -- MIAMI BEACH -- Oral sulfasalazine appears to be a good steroid-sparing alternative for patients whose chronic idiopathic urticaria does not respond...
British Medical Journal - Immune complex haemolytic anaemia associated with sulfasalazine
April 22, 2000 -- Valery Teplitsky, Irit Virag, Aaron Halabe, Department of Internal Medicine E, Hematological Institute, Wolfson Medical Center, Tel Aviv University,...
Skin & Allergy News - Serious infections with biologics stress need for extra vigilance
June 1, 2008 -- LIVERPOOL, ENGLAND -- Serious and even fatal infections continue to occur in patients being treated with tumor necrosis factor-blocking agents and...
Dermatology Nursing - Combining medications is often the best strategy to battle rheumatoid arthritis
April 1, 2008 -- About 2 million Americans have rheumatoid arthritis, a long-term illness that causes joint and tissue inflammation. For patients with rheumatoid...
Internal Medicine News - Extra weight hinders remission in RA patients
February 15, 2008 -- BOSTON -- Overweight patients with early rheumatoid arthritis were less likely to achieve remission during treatment with conventional...
Skin & Allergy News - Obesity hinders remission in RA; infliximab can help
February 1, 2008 -- BOSTON -- Overweight patients with early rheumatoid arthritis were less likely to achieve remission during treatment with conventional...
Internal Medicine News - Certain RA patients benefit from combo therapy
October 1, 2007 -- BARCELONA -- Treatment of early rheumatoid arthritis with a combination of disease-modifying antirheumatic drugs slows radiographic progression...
Original Internist - Curcumin helps maintain remission in patient with ulcerative colitis
September 1, 2007 -- Design & Participants: Randomized, double-blind, placebo-controlled trial of 89 patients (ages 13-65 years) with a diagnosis of ulcerative...
Health News - Hit RA early & hard with combo therapy
July 1, 2007 -- Aggressive, early treatment of rheumatoid arthritis (RA) with combinations of drugs may be the best bet for reducing pain and inflammation and...
